CMC ICOS Biologics, a world-leading manufacturer of clinical and commercial therapeutic proteins, and Harpoon Therapeutics, an immunotherapeutic company, use its proprietary TriTAC ™ technology platform to discover and develop new biologics
CMC ICOS Biologics , the world's leading manufacturer of clinical and commercial therapeutic proteins, and immunology oncology firm Harpoon Therapeutics Inc. use its proprietary TriTAC ™ technology platform to discover and develop new biological agents